on NOVACYT (EPA:ALNOV)
Results of the Novacyt Annual General Meeting
On July 18, 2024, Novacyt SA, a molecular diagnostics company listed on Euronext Growth and AIM, held its Annual General Meeting (AGM). All resolutions presented during the ordinary part were adopted. However, the Extraordinary General Meeting could not be held due to a quorum not being reached.
In addition, Steve Gibson and Joanne Mason were officially appointed to the Novacyt board of directors, as Executive Directors. These appointments aim to strengthen the governance of the company in its next stages of development.
The voting results are now available on the company's website. For any questions, the company invites you to consult its contacts available online.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news